PAZOPANIB for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where PAZOPANIB was used for Bladder cancer.
Most Reported Side Effects for PAZOPANIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,767 | 17.8% | 3,764 | 211 |
| Diarrhoea | 2,907 | 13.7% | 213 | 501 |
| Fatigue | 1,883 | 8.9% | 173 | 315 |
| Nausea | 1,879 | 8.9% | 192 | 413 |
| Malignant neoplasm progression | 1,471 | 6.9% | 570 | 372 |
| Drug ineffective | 1,135 | 5.4% | 160 | 141 |
| Decreased appetite | 1,116 | 5.3% | 196 | 321 |
| Vomiting | 1,072 | 5.1% | 153 | 366 |
| Hypertension | 1,004 | 4.7% | 104 | 271 |
| Malaise | 764 | 3.6% | 148 | 254 |
| Disease progression | 739 | 3.5% | 185 | 82 |
| Asthenia | 727 | 3.4% | 161 | 280 |
| Product use in unapproved indication | 724 | 3.4% | 153 | 60 |
| Weight decreased | 697 | 3.3% | 85 | 168 |
| Hair colour changes | 679 | 3.2% | 41 | 83 |
Other Indications for PAZOPANIB
Product used for unknown indication (5,026)
Renal cancer (3,759)
Renal cell carcinoma (2,799)
Soft tissue sarcoma (1,400)
Metastatic renal cell carcinoma (1,353)
Neoplasm malignant (716)
Malignant connective tissue neoplasm (417)
Renal cancer metastatic (366)
Sarcoma (296)
Thyroid cancer (264)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)